On September 9, 2024, Novo Nordisk announced the initiation of a share repurchase program worth up to DKK 20 billion, starting back on August 7, 2024, with DKK 2.4 billion allocated for purchases until November 4, 2024. As of August 30, 2024, they have repurchased 11,811,313 B shares for a total of DKK 10.4 billion at an average price of DKK 880.47 per share.